Alzamend Neuro, Inc.
ALZNAlzamend Neuro, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Stephan Jackman, with a market cap of $4.6M.
$4.64M-49.8%
We’re still putting together Alzamend Neuro, Inc.’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Earnings
Next report
Jul 28, 2026 (in a month)EPS estimate-$0.67
Profile
CountryUnited States of America
Listed2021
Employees7.0
CEOStephan Jackman
SectorHealthcare
IndustryBiotechnology
Websitealzamend.com
FilingsSEC EDGAR